Physician profile
Wayne Samuel Morris
NPI 1770506578
$11,801.73
in general payments reported to CMS, 2019-2025
36 companies · $1,554 in 2025
The $1,554 reported for 2025 was more than what 93% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,367 · 2020: $1,719 · 2021: $1,511 · 2022: $1,567 · 2023: $1,359 · 2024: $1,725 · 2025: $1,554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,618 · Education: $20.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,617.57 |
| Education | $20.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,900.97 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $2,166.09 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $1,030.87 | 2021-2025 | |
| Glaxosmithkline, LLC. | $808.52 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amarin Pharma, INC. | $737.13 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $728.99 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $725.69 | 2019-2023 | Xarelto |
| Amgen INC. | $621.59 | 2019-2025 | Repatha, Otezla, Evenity |
| Esperion Therapeutics, INC. | $460.64 | 2020-2025 | Nexletol |
| Lilly USA, LLC | $336.91 | 2019-2025 | Mounjaro, Trulicity, Jardiance |
| Abbvie INC. | $193.67 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.52 | 2019-2025 | Jardiance |
| Abbott Laboratories | $117.71 | 2021-2025 | Freestyle Libre 3, Eterna, Afinion 2 |
| Kowa Pharmaceuticals America, INC. | $77.82 | 2019-2021 | |
| Exact Sciences Corporation | $76.36 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $72.87 | 2019-2021 | |
| Dexcom, INC. | $70.46 | 2024-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $61.37 | 2023-2025 | |
| Corcept Therapeutics | $59.75 | 2024-2025 | Korlym |
| Edwards Lifesciences Corporation | $55.23 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Otsuka America Pharmaceutical, INC. | $37.15 | 2022 | |
| Sunovion Pharmaceuticals INC. | $26.73 | 2019 | |
| Medtronic, INC. | $26.51 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $25.38 | 2019 | |
| Valeritas, INC. | $22.76 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.21 | 2021 | |
| Astellas Pharma US INC | $21.99 | 2021 | |
| Mylan Specialty L.P. | $19.06 | 2021 | |
| Allergan, INC. | $17.96 | 2022 | |
| Medtronic Vascular, INC. | $17.20 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.79 | 2025 | Xifaxan |
| Ironwood Pharmaceuticals, INC | $16.50 | 2023 | Linzess |
| Shire North American Group INC | $15.52 | 2019 | |
| Ibsa Pharma INC. | $15.00 | 2024 | Licart, Tirosint |
| Boston Scientific Corporation | $14.98 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.